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Post-myocardial infarction education is effective but not enough on its own. 
 
In this issue of Heart, Giannopoulos et al report that delivering a stand-alone 
educational programme following myocardial infraction (MI) reduces the risk of 
cardiovascular events.1 This single centre trial, based in a University hospital in 
Athens, randomised 329 post-myocardial patients to either an 8-weeks programme 
of structured education plus usual care (intervention) or usual care (control). The 
authors reported that the intervention consisted of 10 hours of contact on risk factor 
management, lifestyle, and drugs, delivered by a non-healthcare personnel with 
interactive patient sessions; aimed at enhancing patient adherence to lifestyle 
change and treatment compliance. At a mean follow-up of 17 months, the authors 
reported a hazard ratio for the primary composite outcome (all-cause death, MI, 
stroke, hospitalisation) of 0.48 (95% CI: 0.32 to 0.73) and Major Adverse 
Cardiovascular and Cerebrovascular Event (MACCE) of 0.49 (0.27 to 0.28). With 
similar mortality in both groups, improvements were driven by reduced rates non-
fatal events in intervention compared to control: MI (13 vs. 22), stroke (2 vs. 7) and 
cardiovascular hospitalisation (14 vs. 22).  
What is the mechanistic basis of this improvement in non-fatal events? As noted by 
the authors, an improvement in risk factors is likely to be a key explanation. Greater 
changes from baseline at 12-months in the education group compared to controls 
were seen in LDLc (median change: -53.5 vs -35.0 mg/dl), systolic blood pressure (-
8.0 vs -2.0 mmHg), and body mass index (0 vs 2.0 kg/m2, P<0.001). Intriguingly, no 
difference in adherence to medication (including use of statins and anti-
hypertensives) over the duration of the study or between the two groups was seen, 
indicating that that risk factor improvement (and consequent reduction in the risk of 
events) was the result of changes in lifestyle behaviour following participation 
education intervention. As behavioural outcomes such as diet and physical activity 
were not reported, that the mechanistic basis of the education intervention was 
improved lifestyle remain a hypothesis.  
In contrast to the Giannopoulos trial, the meta-analysis of the Cochrane review of 
randomised controlled trials published in 2017, showed there to be no strong 
evidence that participation in educational interventions improved either all-cause 
mortality (relative risk (RR) 0.80, 95% CI: 0.60 to 1.05) or cardiovascular events 
(fatal and/or non-fatal MI: RR 0.63, 0.26 to 1.48;  CABG and PCI: RR 0.58, 0.19 to 
1.71; hospitalisations: RR 0.93, 0.71 to 1.21) for people with coronary heart disease 
(CHD). Although based on sizeable literature, i.e., 22 trials in 76,864 participants, the 
Cochrane team identified several limitations in the included evidence base. The case 
mix of participants recruited to trials varied considerably: MI, post-revascularisation, 
and stable angina with a wide range of disease severity and timings from diagnosis 
or event. There was substantial variation in the nature and dose of interventions 
employed by trials, ranging from one trial that employed a single 40-minute face-to-
face teaching session plus a 15-minute follow-up phone call to a four-week 
residential stay followed by 11 months of regular nurse-led follow-up sessions. 
Because of poor reporting of trials methods, there was considerable uncertainty in 
trial methodological quality. Given these limitations, the Cochrane authors called for: 
“...further definitive research into education interventions for people with CHD...” 
Giannopoulos et al respond to this call with a trial that: (1) targets a defined 
homogenous population of MI patients, (2) provides a transparent report of study 
methods, including description of generation of the randomisation sequence, and (3) 
reports a primary outcome assessed by blinded event adjudication.  
To fully understand the applicability of the Giannopoulos trial, it is important that we 
view its educational programme through the lens of a ‘complex intervention’ i.e., as 
an intervention whose efficacy/effectiveness depends on number of interacting 
factors: the theoretical basis for the intervention, the context and method of 
intervention delivery, and how recipients respond to receivership of the intervention 
(e.g., changes in health behaviour).3 Reporting frameworks have been developed for 
complex intervention trial authors to supplement the core Consolidated Standards of 
Reporting Trials (CONSORT) requirements for randomised controlled trials.4,5 
Additional reporting items include the intervention underlying theoretical basis (how 
will the intervention cause change?), method of intervention development (e.g., were 
patients, clinicians, and other key stakeholders involved in the intervention design?), 
fidelity of delivery (e.g., what checks were in place in the trial to check that the 
intervention was delivered as planned?), and the costs and resources (e.g., staffing) 
to deliver of the intervention. That such details were not available, limits our ability to 
judge the applicability of this educational intervention to the UK NHS or other 
healthcare settings.  
So, how should the Giannopoulos trial in inform our clinical practice? Whilst a 
positive study, the addition of the outcome findings of this trial does not overturn the 
‘neutral’ meta-analysis findings of the Cochrane review above. It would therefore 
seem appropriate that we continue to follow the clinical practice conclusions of the 
Cochrane authors and recommend educational interventions as part of a wider 
comprehensive programme of rehabilitation that also includes exercise and 
psychological support, consistent with national guidance for the management of 
people with MI.6,7 
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